Lonza Group (OTCMKTS:LZAGY) Share Price Passes Below Fifty Day Moving Average – Should You Sell?

Lonza Group Ag (OTCMKTS:LZAGY)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $65.99 and traded as low as $62.68. Lonza Group shares last traded at $63.85, with a volume of 63,905 shares trading hands.

Analyst Ratings Changes

A number of research firms recently commented on LZAGY. Zacks Research lowered shares of Lonza Group from a “hold” rating to a “strong sell” rating in a research report on Wednesday, February 4th. Royal Bank Of Canada raised shares of Lonza Group from a “hold” rating to a “moderate buy” rating in a report on Wednesday, February 11th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold”.

Lonza Group Trading Up 2.5%

The stock has a 50-day moving average of $65.99 and a 200 day moving average of $67.27. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.24 and a quick ratio of 1.77.

About Lonza Group

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.